Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,526,286,678
+$199,558,004 QoQ
Shares Held
10,039,289
-6.2% QoQ
Ownership
0.568%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#26
of 4,167 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Amundi holds $20,539,050,875 across 14 Drug Manufacturers - General names. ABBV ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,808,143 | $5,767,031,432 | |
| 2 | JNJ |
Johnson & Johnson
|
13,117,657 | $3,331,491,343 | |
| 3 | AZN |
Astrazeneca PLC
|
16,422,784 | $3,114,088,296 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
10,039,289 | $2,526,286,678 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,342,274 | $1,585,982,207 | |
| 6 | AMGN |
Amgen Inc
|
3,890,189 | $1,408,715,236 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,772,438 | $1,234,649,812 | |
| 8 | PFE |
Pfizer Inc
|
33,533,616 | $807,489,467 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,526,286,678 | 10,039,289 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $2,326,728,674 | 10,698,095 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,387,813,260 | 10,450,406 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,433,095,713 | 10,508,317 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,687,971,846 | 9,093,696 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,395,052,028 | 6,658,324 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,483,314,487 | 8,347,296 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,506,751,254 | 7,629,893 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,219,425,201 | 7,109,522 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,147,543,746 | 6,301,723 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,236,958,904 | 7,981,925 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,224,876,536 | 8,217,339 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,220,075,793 | 9,055,710 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,378,902,216 | 8,652,207 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $995,083,340 | 6,157,313 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $692,433,668 | 5,159,330 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $843,342,136 | 5,506,282 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $765,678,910 | 4,723,206 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $708,051,676 | 5,229,333 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $627,471,586 | 5,816,924 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $515,976,452 | 4,580,757 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||